India boosts medical device manufacturing with billions in fresh incentives

The Indian government has extended its Production-Linked Incentive (PLI) scheme for medical devices significantly, pushing the deadline from its original end date to 2035-36. This move opens up a fresh round of applications for manufacturers, with a substantial incentive pool of ₹2,700 crore (approximately $325 million USD) now available to support domestic production of items like implants, diagnostic kits, and surgical equipment.

For the global medtech supply chain and healthcare providers, this long-term commitment aims to reduce import dependency and potentially stabilize costs for critical devices. It signals a major opportunity for companies to invest in local manufacturing capacity, which could reshape supply lines and create jobs in India's growing healthcare sector. The extension provides over a decade of policy certainty for an industry crucial to public health infrastructure.